Risultati della ricerca - Yiming Mu
- Mostra 1 - 20 risultati su 25
- Vai alla pagina seguente
-
1
-
2
Effects of SGLT2 inhibitors on development and progression of kidney disease in Chinese patients with type 2 diabetes: A multicentre, prospective real‐world study di Yun Wang, Yajing Wang, Yiming Mu, Yu Cheng
Pubblicazione 2025Testo
Artículo Open Access -
3
-
4
Association Between Skin Autofluorescence and Coronary Heart Disease in Chinese General Population: A Cross‐Sectional Study di Qingzheng Wu, Yu Cheng, Hongyan Liu, Yuepeng Wang, Bing Li, Yiming Mu
Pubblicazione 2025Testo
Artículo Open Access -
5
Efficacy and safety of once‐weekly semaglutide 2.4 mg for weight management in participants from China: A prespecified analysis of the STEP 7 randomized clinical trial di Weijun Gu, Yibing Lu, Xinhua Ye, Guoyue Yuan, Dongmei Liu, Zewei Shen, Ning Zu, Yiming Mu
Pubblicazione 2025Testo
Artículo Open Access -
6
Efficacy and safety of iGlarLixi versus IDegAsp by baseline β‐cell function in Chinese people with type 2 diabetes: Exploratory analyses of the Soli‐D study di Weijun Gu, Xiaohong Wu, Minlu Zhang, Xinyi Wang, Qin Du, Lei Kang, Felipe Lauand, Agustina Alvarez, Yiming Mu
Pubblicazione 2025Testo
Artículo Open Access -
7
Association of advanced glycation end products with ear lobe crease: A cross‐sectional study di Yuepeng Wang, Yu Xin, Binqi Li, Qingzheng Wu, Ping An, Bing Li, Yijun Li, Li Zang, Weijun Gu, Yiming Mu
Pubblicazione 2024Testo
Artículo Open Access -
8
Exogenous Mitochondrial Pretreatment Enhances the Therapeutic Effect of UC‐MSCs on NAFLD in Type 2 Diabetic Mice by Mediating Mitochondrial Transfer di Ruofan Hu, Jian Zhao, Yu Cheng, Wanlu Su, Rui Ren, Haixia Zhang, Yue Zhang, Anning Wang, Yiming Mu, Songyan Yu
Pubblicazione 2025Testo
Artículo Open Access -
9
Association between weight‐adjusted‐waist index and incident carotid atherosclerosis in the general adult population in Chinese communities: Evidence from the REACTION cohort study... di Qingzheng Wu, Shuying Li, Wei Jing, Zixin Guo, Jing Yang, Zhiwei Li, Haixia Zhang, Yue Zhang, Binqi Li, Bing Li, Yiming Mu
Pubblicazione 2025Testo
Artículo Open Access -
10
Clinical Characteristics and Management of Hypercalcemic Crisis in 155 Patients: A Single Center Retrospective Study di Yuqing Qu, Yang Liu, Xianling Wang, Qinghua Guo, Jin Du, Yu Pei, Jianming Ba, Weijun Gu, Jingtao Dou, Zhaohui Lv, Yiming Mu
Pubblicazione 2024Testo
Artículo Open Access -
11
Early Glycemic Control With iGlarLixi Versus IDegAsp in Chinese Adults With Type 2 Diabetes: A Post Hoc Analysis of the Soli‐D Study di Xiaohong Wu, Ying Zhang, Ziling Li, Agustina Alvarez, Felipe Lauand, Lydie Melas‐Melt, Minlu Zhang, Lei Kang, Qin Du, Jie Zhang, Yiming Mu
Pubblicazione 2025Testo
Artículo Open Access -
12
Exosomes derived from umbilical cord‐derived mesenchymal stem cells exposed to diabetic microenvironment enhance M2 macrophage polarization and protect against diabetic nephropathy... di Wanlu Su, Yaqi Yin, Jian Zhao, Ruofan Hu, Haixia Zhang, Jia Hu, Rui Ren, Yue Zhang, Anning Wang, Zhaohui Lyu, Yiming Mu, Yu Cheng
Pubblicazione 2024Testo
Artículo Open Access -
13
Mesenchymal Stem Cells Polarize Macrophages to an Anti‐Inflammatory Phenotype to Ameliorate Diabetic Nephropathy di Linxi Zhang, Songyan Yu, Yu Cheng, Xiafang Lin, Zhengyuan Gong, Jing Xue, Bing Li, Yaqi Yin, Junyan Zou, Rui Wei, Tianpei Hong, Yiming Mu
Pubblicazione 2026Testo
Artículo Open Access -
14
Remnant cholesterol is more positively related to diabetes, prediabetes, and insulin resistance than conventional lipid parameters and lipid ratios: A multicenter, large sample sur... di Binqi Li, Yang Liu, Xin Zhou, Lulu Chen, Li Yan, Xulei Tang, Zhengnan Gao, Qin Wan, Zuojie Luo, Guijun Qin, Guang Ning, Weijun Gu, Yiming Mu
Pubblicazione 2024Testo
Artículo Open Access -
15
The efficacy and safety of iGlarLixi versus IDegAsp in Chinese people with type 2 diabetes suboptimally controlled with oral antidiabetic drugs: The Soli‐D randomized controlled tr... di Ming Liu, Weijun Gu, Li Chen, Yanbing Li, Hongyu Kuang, Jianling Du, Agustina Alvarez, Felipe Lauand, Elisabeth Souhami, Jiewen Zhang, Weiya Xu, Qin Du, Yiming Mu
Pubblicazione 2024Testo
Artículo Open Access -
16
Safety and efficacy of hybrid closed‐loop insulin pump therapy in adolescents and adults with type 1 diabetes in China di Jing Shen, Tianshu Zeng, Xia Li, Chao Zheng, Yufeng Li, Xiaohong Wu, Hui Yao, Linqi Chen, Yang Liu, Weiwei Zhu, Junfen Fu, Weigang Zhao, Yiming Mu
Pubblicazione 2025Testo
Artículo Open Access -
17
Crosstalk Between Intratumoral Microbes and Tumor Immunity: Implications for Tumor Therapy di Fengxue Li, Lili Qiao, Xinquan Liang, Yingying Zhang, Ning Liang, Jian Xie, Guodong Deng, Yuying Hao, Pingping Hu, Xue Wu, Fangjie Ding, Can Feng, Yiming Mu, Jiandong Zhang
Pubblicazione 2026Testo
Artículo Open Access -
18
Clinical characteristics and complication risks in data‐driven clusters among Chinese community diabetes populations di Binqi Li, Zizhong Yang, Yang Liu, Xin Zhou, Weiqing Wang, Zhengnan Gao, Li Yan, Guijun Qin, Xulei Tang, Qin Wan, Lulu Chen, Zuojie Luo, Guang Ning, Weijun Gu, Yiming Mu
Pubblicazione 2024Testo
Artículo Open Access -
19
Glycaemic Outcomes of a Novel Model‐Predictive‐Control‐Based Hybrid Closed‐Loop System in Chinese Adolescents and Adults With Type 1 Diabetes: A Multicentre Pivotal Trial di Yang Liu, Yun Wang, Wei Wu, Yimei Chen, Tianshu Zeng, Xia Li, Chao Zheng, Yufeng Li, Xiaohong Wu, Hui Yao, Linqi Chen, Weiwei Zhu, Junfen Fu, Jing Shen, Yiming Mu
Pubblicazione 2026Testo
Artículo Open Access -
20
Development and validation of a machine learning‐based model to predict isolated post‐challenge hyperglycemia in middle‐aged and elder adults: Analysis from a multicentric study... di Rui Hou, Jingtao Dou, Lijuan Wu, Xiaoyu Zhang, Changwei Li, Weiqing Wang, Zhengnan Gao, Xulei Tang, Li Yan, Qin Wan, Zuojie Luo, Guijun Qin, Lulu Chen, Jianguang Ji, Yan He, Wei Wang, Yiming Mu, Deqiang Zheng
Pubblicazione 2024Testo
Artículo Open Access